scholarly journals Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice

2006 ◽  
Vol 120 (3) ◽  
pp. 585-593 ◽  
Author(s):  
Toshiyasu Ojima ◽  
Makoto Iwahashi ◽  
Masaki Nakamura ◽  
Kenji Matsuda ◽  
Mikihito Nakamori ◽  
...  
2006 ◽  
Vol 8 (3) ◽  
pp. 714-720 ◽  
Author(s):  
Clara Maria Ausiello ◽  
Giorgio Fedele ◽  
Raffaella Palazzo ◽  
Fabiana Spensieri ◽  
Alessandra Ciervo ◽  
...  

2004 ◽  
Vol 5 (9) ◽  
pp. 909-918 ◽  
Author(s):  
Till A Röhn ◽  
Marianne Boes ◽  
Dirk Wolters ◽  
Sebastian Spindeldreher ◽  
Bernd Müller ◽  
...  
Keyword(s):  
T Helper ◽  

2009 ◽  
Vol 10 (4) ◽  
pp. 394-402 ◽  
Author(s):  
Hideki Nakano ◽  
Kaifeng Lisa Lin ◽  
Manabu Yanagita ◽  
Chantal Charbonneau ◽  
Donald N Cook ◽  
...  

Blood ◽  
2009 ◽  
Vol 114 (4) ◽  
pp. 796-806 ◽  
Author(s):  
Manuela Del Cornò ◽  
Alessandro Michienzi ◽  
Andrea Masotti ◽  
Letizia Da Sacco ◽  
Gian Franco Bottazzo ◽  
...  

Abstract Toll-like receptor (TLR) signaling activation by pathogens is critical to the induction of immune responses, and demands tight regulation. We describe in this study that CC chemokine ligand 2 (CCL2) secretion triggered by TLR4 or TLR8 engagement is strongly inhibited upon simultaneous activation of both TLRs in human monocyte-derived dendritic cells (DCs). Impaired CCL2 secretion occurs concomitantly to interleukin-12 up-regulation, being part of a complex regulatory circuit ensuring optimal T helper type 1 polarization. Interestingly, triggering selected TLRs or their combinations differently affects nuclear factor-κB p65 activation and microRNA expression. Overall, these results indicate that CCL2 supplies an important immunomodulatory role to DCs, and may contribute to dictate the cytokine profile in T helper type 1 responses induced by DCs.


Sign in / Sign up

Export Citation Format

Share Document